Bone sarcomas: from biology to targeted therapies.

Bone sarcomas: from biology to targeted therapies.

Item
http://www.wikidata.org/entity/Q41923624
Bisphosphonate therapy in pediatric patientsManagement of Ewing sarcoma family of tumors: Current scenario and unmet needReceptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersOff-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder.Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.
P2860

Bone sarcomas: from biology to targeted therapies.

Item
http://www.wikidata.org/entity/Q41923624
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bone sarcomas: from biology to targeted therapies.
@en
type
label
Bone sarcomas: from biology to targeted therapies.
@en
prefLabel
Bone sarcomas: from biology to targeted therapies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Bone sarcomas: from biology to targeted therapies
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932